Next Article in Journal
An Overview of Pancreatic Neuroendocrine Tumors and an Update on Endoscopic Techniques for Their Management
Previous Article in Journal
Non-Professional Phagocytosis Increases in Melanoma Cells and Tissues with Increasing E-Cadherin Expression
Previous Article in Special Issue
Psychosocial Oncology: Optimizing Outcomes through Interdisciplinary Care in Head and Neck Oncology
 
 
Article
Peer-Review Record

Validation of the Canadian Version of the Shame and Stigma Scale for Head and Neck Cancer Patients

Curr. Oncol. 2023, 30(8), 7553-7565; https://doi.org/10.3390/curroncol30080548
by Irene Bobevski 1,2,*, David W. Kissane 1,2, Justin Desroches 3, Avina De Simone 3 and Melissa Henry 4,5
Reviewer 1:
Curr. Oncol. 2023, 30(8), 7553-7565; https://doi.org/10.3390/curroncol30080548
Submission received: 13 July 2023 / Revised: 7 August 2023 / Accepted: 8 August 2023 / Published: 11 August 2023
(This article belongs to the Special Issue Psychosocial Effects of Head and Neck Cancer)

Round 1

Reviewer 1 Report

great work as you are making sure the tool is relevant for the Canadian context

wonderful

and you did in both official languages

I just have some questions which are inside the  manuscript about the number of measures, important to address the limitations and clarify some part of the design

Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

Dear Authors

This paper deals with a very interesting and pertinent topic since this type of patients require a lot of care in addition to the physical ones.

The validation and adaptation of scales to detect health problems is fundamental to correct these problems in all societies and in all types of people.

Technically the paper seems to me to be totally correct and the statistical analyses used are appropriate to achieve the objective.

I will only make a few minor comments

Minor issues

In the Abstract it is mentioned that 258 patients have been taken. In the results, 254 patients are mentioned.

It would be good to clarify what the correct figure is. It is also said that it is a strength of the work to have 258 patients. Then a study should have been made of the sample size and how this sample has been taken. In another case a study of the statistical power of this sample can be shown.

Furthermore, I consider that the sample size is not a result and should be, even before the Data Analysis paragraph.

Regarding the descriptive, in this type of questionnaires, I consider that it is good to use also the mode since it is the most repeated result and therefore the most accepted by the majority. And it has a very good interpretation.

The tables should be self-explanatory, so all tables should be accompanied by an explanation of the acronyms (e.g. SD, PSI, IQR....).

Finally, I would like to make a recommendation for future work. It would be of great interest to carry out a study with this questionnaire validated with a gender perspective comparing the SSS results between men and women with face and neck cancer.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop